Literature DB >> 23045599

Keys to personalized care in pancreatic oncology.

Christopher H Crane, Christine A Iacobuzio-Donahue.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23045599     DOI： 10.1200/JCO.2012.45.1799

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Transport properties of pancreatic cancer describe gemcitabine delivery and response.

Authors:  Eugene J Koay; Mark J Truty; Vittorio Cristini; Ryan M Thomas; Rong Chen; Deyali Chatterjee; Ya'an Kang; Priya R Bhosale; Eric P Tamm; Christopher H Crane; Milind Javle; Matthew H Katz; Vijaya N Gottumukkala; Marc A Rozner; Haifa Shen; Jeffery E Lee; Huamin Wang; Yuling Chen; William Plunkett; James L Abbruzzese; Robert A Wolff; Gauri R Varadhachary; Mauro Ferrari; Jason B Fleming
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

2.  Nanoparticle formulation of ormeloxifene for pancreatic cancer.

Authors:  Sheema Khan; Neeraj Chauhan; Murali M Yallapu; Mara C Ebeling; Swathi Balakrishna; Robert T Ellis; Paul A Thompson; Pavan Balabathula; Stephen W Behrman; Nadeem Zafar; Man M Singh; Fathi T Halaweish; Meena Jaggi; Subhash C Chauhan
Journal:  Biomaterials       Date:  2015-03-26       Impact factor: 12.479

Review 3.  Evolution and dynamics of pancreatic cancer progression.

Authors:  S Yachida; C A Iacobuzio-Donahue
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

4.  Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.

Authors:  Vicente Valero; Tyler J Saunders; Jin He; Matthew J Weiss; John L Cameron; Avani Dholakia; Aaron T Wild; Eun Ji Shin; Mouen A Khashab; Anne Marie O'Broin-Lennon; Syed Z Ali; Daniel Laheru; Ralph H Hruban; Christine A Iacobuzio-Donahue; Joseph M Herman; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

5.  Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.

Authors:  Eugene J Koay; Flavio E Baio; Alexander Ondari; Mark J Truty; Vittorio Cristini; Ryan M Thomas; Rong Chen; Deyali Chatterjee; Ya'an Kang; Joy Zhang; Laurence Court; Priya R Bhosale; Eric P Tamm; Aliya Qayyum; Christopher H Crane; Milind Javle; Matthew H Katz; Vijaya N Gottumukkala; Marc A Rozner; Haifa Shen; Jeffrey E Lee; Huamin Wang; Yuling Chen; William Plunkett; James L Abbruzzese; Robert A Wolff; Anirban Maitra; Mauro Ferrari; Gauri R Varadhachary; Jason B Fleming
Journal:  Phys Biol       Date:  2014-11-26       Impact factor: 2.583

Review 6.  Pancreatic cancer biology and genetics from an evolutionary perspective.

Authors:  Alvin Makohon-Moore; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Cancer       Date:  2016-07-22       Impact factor: 60.716

7.  Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival.

Authors:  Yi Zhong; Yoshiki Naito; Leslie Cope; Salvador Naranjo-Suarez; Tyler Saunders; Seung-Mo Hong; Michael G Goggins; Joseph M Herman; Christopher L Wolfgang; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

8.  UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.

Authors:  Javier Martinez-Useros; Tihomir Georgiev-Hristov; María Jesús Fernández-Aceñero; Aurea Borrero-Palacios; Alberto Indacochea; Santiago Guerrero; Weiyao Li; Arancha Cebrián; Teresa Gómez Del Pulgar; Alberto Puime-Otin; Laura Del Puerto-Nevado; María Rodríguez-Remírez; Nuria Pérez; Angel Celdrán; Fátima Gebauer; Jesus Garcia-Foncillas
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

9.  Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.

Authors:  Jae Keun Park; Ji Hyeon Lee; Dong Hyo Noh; Joo Kyung Park; Kyu Taek Lee; Jong Kyun Lee; Kwang Hyuck Lee; Kee-Taek Jang; Juhee Cho
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

10.  Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 "STARD Compliant".

Authors:  J Martinez-Useros; T Georgiev-Hristov; A Borrero-Palacios; M J Fernandez-Aceñero; M Rodríguez-Remírez; L Del Puerto-Nevado; A Cebrian; M T Gomez Del Pulgar; A Cazorla; R Vega-Bravo; N Perez; A Celdran; J Garcia-Foncillas
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.